Used in research and therapeutic development targeting inflammatory and autoimmune diseases due to its ability to neutralize interleukin-6 (IL-6) activity. It serves as a reference tool in assays evaluating IL-6 pathway inhibition, particularly in studies related to cytokine signaling and immune modulation. This antibody has been utilized in preclinical models of chronic inflammation, rheumatoid arthritis, and certain cancers where IL-6 plays a key role in disease progression. Its design also supports use in comparative studies with other anti-IL-6 therapies and in the development of biosimilars or novel biologics.